This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2023) scheduled during April 24-26, 2023 in Orlando, Florida, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at email@example.com or call + 1 (702) 988 2320.
Theragnosis is a patient-management technique that combines diagnosis and treatment. Theragnosis integrates the domains of tumor diagnosis and therapy in oncology in order to improve upon existing procedures. The prospects for diagnosing disease, directing treatment, and monitoring outcomes bring up a new chapter in precision medicine. To develop efficient new targeted therapies with adequate benefit/risk to patients and a better molecular understanding of how to optimise drug selection, theragnostic encompasses a wide range of subjects, including personalised medicine, pharmacogenomics, and molecular imaging. The imaging agents and medications must be administered efficiently for successful theragnosis applications, resulting in appropriate imaging signal or drug concentration in the targeted disease location.